Amgen was looking into buying more small-sized but profitable firms after its successful bid with Onyx Pharmaceuticals.
Onyx Pharmaceuticals Inc.
Breaking News
- Businessman Who Shot His Wife to Death Thinking She Was an Intruder Gets Only 12 Years in Prison
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- HYBE Files Police Report Against NewJeans Label CEO Min Hee-Jin Amid ADOR Exec's Emotional Press Conference
Amgen Inc. might announced the agreement to acquire Onyx Pharmaceuticals Inc. for USD 125 per share piece as soon as Monday.
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
- MSC Darwin Ship Targeted by Yemen's Houthis in Gulf of Aden
- Norway Airspace Shuts Down for Several Hours Following Technical Glitch
- Google's Parent Company Alphabet Approves First-Ever Dividend as Shares Skyrocket
